Large two-topping carryout pizzas are $6.99 each from June 2-8 Domino's Pizza Inc. (Nasdaq: DPZ) is kicking off June with a special deal: customers can carry out large two-topping pizzas for $6.99 each from June 2-8. https://mma.prnewswire.com/media/2700052/Domino_s__Weeklong_Carry_Out_Special.jpg “Summer is unofficially here, and Domino's is celebrating by doing what we do best: offering delicious pizza at […]
New York, NY, June 02, 2025 (GLOBE NEWSWIRE) — The annual electricity consumption of global cryptocurrency mining has exceeded Argentina's national electricity consumption (data from Cambridge University). Today, when carbon emission reduction has become a consensus, “green mining” has gone from a slogan to a rigid demand. As one of the first platforms to deeply
(NASDAQ:REGN), New licensing agreement with Hansoh Pharma provides Regeneron with HS-20094, a GLP-1/GIP receptor agonist in advanced stages of clinical development in China Phase 2 data suggest potentially similar profile to the only FDA-approved GLP-1/GIP receptor agonist Key complementary asset enables synergy and flexibility across Regeneron's broad pipeline of obesity and metabolic programs focused on
Green electricity + cloud mining new trend: RichMiner's three secrets to create low-carbon passive income Introduction: When green electricity meets cloud mining GlobeNewswire June 02, 2025 New York, NY, June 02, 2025 (GLOBE NEWSWIRE) — The annual electricity consumption of global cryptocurrency mining has exceeded Argentina's national electricity consumption (data from Cambridge University). Today, when
Regeneron Expands Clinical-Stage Obesity Portfolio with Strategic In-Licensing of Novel Dual GLP-1/GIP Receptor Agonist GlobeNewswire June 02, 2025 New licensing agreement with Hansoh Pharma provides Regeneron with HS-20094, a GLP-1/GIP receptor agonist in advanced stages of clinical development in China Phase 2 data suggest potentially similar profile to the only FDA-approved GLP-1/GIP receptor agonist Key
— Event will feature Aravindhan Veerapandiyan, M.D., principal investigator of the AFFINITY DUCHENNE® trial REGENXBIO Inc. (Nasdaq: RGNX) today announced that it will host a webcast to discuss new interim functional data from the Phase I/II AFFINITY DUCHENNE® trialof RGX-202, the company's next-generation investigational gene therapy for the treatment of Duchenne muscular dystrophy. The webcast
Elaine Duke, PatrickLechleitner, Katie Tobin, Ryan Scudder & Tim Devine join Cambridge Global Advisors bringing decades of homeland security experience With U.S. border policy taking center stage in the Trump Administration, and unprecedented budget increases, organizations require trusted advisors who possess firsthand experience in leading operations, shaping policy, and implementing programs at the highest levels
(NASDAQ:QURE), ~ Alignment with FDA continues to support Accelerated Approval pathway ~ ~ BLA submission planned for first quarter of 2026 ~ ~ Conference call today at 8:30 a.m. ET ~ LEXINGTON, Mass. and AMSTERDAM, June 02, 2025 (GLOBE NEWSWIRE) — uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients
uniQure Provides Regulatory Update on AMT-130 for Huntington's Disease GlobeNewswire June 02, 2025 ~ Alignment with FDA continues to support Accelerated Approval pathway ~ ~ BLA submission planned for first quarter of 2026 ~ ~ Conference call today at 8:30 a.m. ET ~ LEXINGTON, Mass. and AMSTERDAM, June 02, 2025 (GLOBE NEWSWIRE) — uniQure N.V.
Atlanta Parrot Head Club member, Josh Jones, wins national design contest for graphic to be used in all ongoing outreach for the Parrot Head Reef- The Parrot Head Reef is organized by Eternal Reefs, Reef Innovations, the Reef Ball Foundation and Parrot Heads in Paradise and will be deployed off Key West in 2026 tohonor